Illumina, Inc. (ILMN) Rating Reiterated by Evercore ISI


's stock had its "hold" rating reaffirmed by research analysts at Evercore ISI in a research note issued on Tuesday. They currently have a $139.00 price objective on the life sciences company's stock.



from Biotech News